subtype-specific sequences of class 1 protein in the induction of bactericidal antibodies and show that construction of a multivalent OMC-based vaccine should be feasible.
Meningococcal meningitis is a severe, life-threatening infection for which no adequate vaccine exists. Vaccines containing the capsular polysaccharide provide limited protection against infection caused by strains of serogroups A and C. Immunity is, however, of short duration, and infants fail to respond. Polysaccharide vaccines do not induce protection against Neisseria meningitidis group B, the predominant cause of infection in western countries, because of the poor itnmunogenicity of the group B polysaccharide in humans. Therefore, vaccines derived from outer membranes are currently being evaluated for their efficacy in preventing meningococcal disease (5, 28) . Several studies suggest that such vaccines will probably be effective but will only protect against strains with the same sero(sub)type (9, 14, 16) . These vaccines are prepared from wild-type strains and contain class 1, 2 or 3, 4, and sometimes 5 outer membrane proteins (OMPs) in addition to some ill-defined high-molecularweight components and lipopolysaccharide (LPS) . They can properly be referred to as first-generation outer membrane complex (OMC) vaccines.
Meningococci are heterogeneous with respect to class 1 OMP (the subtype antigen, e.g., P1.7,16), class 2 or 3 OMP (the serotype antigen, e.g., serotype 15), LPS (the immunotype, e.g., L3), and class 5 OMP (e.g., P5.1) (see reference 6) . The class 5 OMP shows a high degree of inter-as well as intrastrain variability, the extent of which is currently unknown (3) . The in vitro bactericidal activity and infant rat protection capacity of a pool of monoclonal antibodies revealed a hierarchy of protective capacity, with class 1 OMP > LPS > class 2 or 3 OMP (19) . The extent of heterogeneity of class 1 OMP is limited, with seven subtypes representing more than 80% of a worldwide collection of group B meningococci (2) . The combination of OMCs from so many strains into a single vaccine preparation is not * Corresponding author. feasible, however, since it would contain too much endotoxin (LPS) and too many nonprotective OMPs. To overcome this problem, we have investigated the possibility of constructing a meningococcal strain in which a nonprotective OMP is replaced by a protective one from another sero(sub)type. If successful, such an approach could lead to a multivalent, second-generation meningococcal vaccine.
The class 1 OMP is a cation-selective porin (22) expressed by almost all meningococcal isolates, although there is considerable variation in its level of expression (13) . Antigenic diversity is determined by two short variable regions which form major cell-surface-exposed loops of the protein (10, 25) . Monoclonal antibodies directed against these subtype-specific epitopes have been shown to be particularly effective in bactericidal assays and in conferring protection in an animal model (18, 19) . The isolation of a spontaneous, nonreverting mutant of strain H44/76 deficient in class 3 OMP has been described previously (22 (11) . Plasmid pCO14 carries the class 1 gene from strain 2996 (25) . Plasmid constructions were done with standard recombinant DNA techniques (17) . Restriction fragments were purified from low-melting-point agarose gels (NuSieve GTG Agarose, FMC BioProducts). Chromosomal DNA was isolated from meningococci by the method of Ausubel et al. (4) . For Southern blotting, digested DNA was transferred from agarose gels to Hybond-N membranes (Amersham). Hybridization with oligonucleotides derived from gonococcal opa genes has been described previously (24) . For hybridization with restriction fragments, the nonradioactive DNA labeling and detection kit with the luminescent substrate AMPPD was used according to the instructions provided by the manufacturer (Boehringer Mannheim).
Transformation of meningococci. Meningococci were grown overnight on GC agar, resuspended in Mueller-Hinton broth containing 10 mM MgCl2 to an optical density at 620 nm of 0.2 to 0.3, and incubated for 3 h at 37°C with 1 ,ug of undigested plasmid DNA per ml. Appropriate dilutions were plated and grown overnight. Transformants expressing the P1.2 epitope of the incoming class 1 gene were identified by using a colony blot procedure. Plates were overlaid with nitrocellulose filters (Schleicher & Schuell); when completely wet, the filters were removed, immersed in phosphate-buffered saline (PBS) with 0.1% Tween 80, and inactivated at 56°C for 60 min. After the excess cells were wiped off, the filters were blocked in PBS containing 0.1% Tween 80 and 0.3% casein hydrolysate (ICN Biochemicals). Incubation with monoclonal antibody and protein A-peroxidase conjugate was done for 60 min at room temperature, with appropriate dilutions in the same buffer as that used for blocking. The filters were washed several times in PBS containing 0.1% Tween 80. Peroxidase substrate was prepared by dissolving 24 mg of 3,3',5,5'-tetramethylbenzidine and 80 mg of dioctyl sulfosuccinate in 10 ml of 96% ethanol. This solution was added to 30 ml of a 10 mM Na2HPO4-5 mM citric acid buffer (pH 5.0), and 20 ,ul of 30% H202 was added. Positive colonies were picked from the regrown plates, streaked, and retested until pure stocks were obtained.
Isolation of outer membrane complexes. Meningococci were grown in Mueller-Hinton broth and used for the isolation of OMCs by sarcosyl extraction as described previously (25) . The protein composition was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as described by Lugtenberg et al. (8); protein content was determined by using the bicinchoninic acid protein assay reagent (Pierce Chemical Co.), with bovine serum albumin as a standard. Immunoblotting with subtype-specific monoclonal antibodies (2) was done as described previously (12) .
Immunization and serology. Outbred 14-to 17-g female NIH mice were immunized subcutaneously with 0.5, 2.5, or 12.5 ,ug of OMC protein in saline and 0.5 mg of AlPO4 in a volume of 0.5 ml. Immunization was carried out twice, with a 4-week interval. Animals were bled at week 6. Sera were analyzed in an enzyme-linked immunosorbent assay (ELISA) using OMCs as coat antigens (25) . Bactericidal titers of the sera were determined as described previously (15) Insertion of a second class 1 gene into the meningococcal chromosome. Mutational removal of class 3 OMP from strain H44/76 does not result in an increased expression of class 1 or some other OMP (22) . Insertion of a second class 1-encoding gene into this mutant strain could thus conceivably lead to a net increase in class 1 OMP expression. Transformation of HIII5 with uncut plasmid pMC22 resulted in P1.2+ colonies (identified in a colony blot) appearing at a frequency of 10-3 to 10-4. Ten such transformants were purified and tested for the simultaneous presence of the P1.16 epitope. In nine cases, the P1.16 epitope was lost, which indicates that in these transformants the incoming P1.5,2 gene has replaced (part of) the resident P1.7,16 gene. In one transformant, both the P1.2 and the P1.16 epitopes were present, most likely through insertion of the P1.5,2 gene into the class 5 gene. Isolation of OMCs and analysis by SDS-PAGE showed that this transformant, termed HII15/2, does indeed produce an additional class 1 protein (Fig. 2) . However, the level of expression of this P1.5,2 protein is considerably lower than that of the P1.7,16 protein. This is also observed in transformants where the P1.5,2 gene has replaced the entire P1.7,16 gene and is caused by differences in the promoter regions (23). From such transformants, spontaneous variants with an increased level of P1.5,2 expression can be isolated with the colony blot procedure and occur at a frequency of approximately 10-. A similar variant was also isolated from HIII5/2; in this strain, termed HIII5/2,1-2 (or strain 1-2), the level of P1.5,2 expression is increased to that of P1.7,16 (Fig.  2) . The identity of the two types of class 1 protein was confirmed by immunoblotting with monoclonal antibodies specific for the P1.2 and P1.16 epitopes (Fig. 2B) . A comparison of strain 1-2 with the parent strain HIIIS shows that P1.7,16 expression has not been affected; thus, the total level of class 1 expression has been doubled in strain 1-2, consisting of equal amounts of P1.7,16 and P1.5,2 proteins. This level of P1.5,2 expression is higher than that in strain 2996, where it is higher than that in HIII5/2 (Fig. 2) . Apparently, class 1 gene expression is subject to complex regulation, the mechanism of which is currently under investigation (23) . By using monoclonal antibodies specific for the P1.7, 16, 5, and 2 subtypes in a whole-cell ELISA, it was demonstrated that strain 1-2 does indeed express all four epitopes at the cell surface (not shown); no difference in binding was observed between strain 1-2 and strains which express the P1.7,16 and P1.5,2 proteins separately. The growth rate of strain 1-2 was found to be indistinguishable from that of the parent strain HIII5. The expression of both class 1 proteins was stable upon repeated serial passage, both on plates and in liquid media.
The results presented demonstrate that strain 1-2 produces two distinct class 1 proteins. To verify that the second, transforming gene has indeed been inserted into the class 5 gene, Southern blotting experiments were performed. Chromosomal DNA was isolated from strain HII15 and its derivatives HIII5/2 and 1-2, digested with EcoRI, and probed with purified restriction fragments from either the class 1 or class 5 gene (Fig. 3) . As shown in Fig. 1 , insertion of the P1.5,2 gene into the chromosomal equivalent of the class 5 gene carried on plasmid pMC22 will result in the generation of a 2.7-kb EcoRI fragment consisting of both class 1 and class 5 sequences. A fragment of this size, binding to both probes, was absent from the parent strain HII15 but present in HIII5/2 and 1-2 (Fig. 3) . The band showing the strongest signal with the class S probe in HIII5 (at approximately 16 kb) is reduced in strains HIII5/2 and 1-2, indicating that it is a double band. No difference between the latter two strains was found. It can thus be concluded that the P1.5,2 gene has indeed been inserted into the chromosome through homologous recombination within the flanking class 5 sequences and, furthermore, that the increased expression of this gene in strain 1-2 does not result from an additional gene duplication.
Immunization with OMCs. To assess the immunogenicity of the constructed strain, OMCs were isolated and used for the immunization of mice. For comparison, strains H44/76 and 2996 were included, as well as HI5 and HIII5, which are derivatives of H44/76 deficient in class 1 and class 3 proteins, respectively (22) . The resulting antisera were tested in an ELISA against OMCs (Table 1) . When H44/76 is used as the immunogen, high antibody titers against class 1 protein are obtained; those against class 3 protein are considerably lower. Antibodies cross-reacting with the heterologous strain 2996 are present in low amounts. Removal of class 1 protein results in a strong reduction of the antibody titers against H44/76, whereas removal of class 3 has hardly any (Fig. 2) ; since none is present in the other strains, this does not affect the conclusions regarding the role of class 1 and 3 proteins. Similar results were obtained when the antisera were tested for their bactericidal activity against H44/76 and 2996 ( Table 2 ). The titers of bactericidal antibodies against H44/76 are strongly reduced after removal of class 1 protein from the immunizing OMCs, whereas removal of class 3 protein has no effect. Hardly any cross-reacting antibodies are induced. With strain 1-2, the addition of the P1.5,2 protein has conferred high bactericidal activity against both strain 2996 and strain H44/76, which demonstrates that a truly bivalent strain has been obtained. Thus, antibodies against the variable regions of class 1 protein are responsible for most of the bactericidal activity.
Conclusions. Previous studies have demonstrated that monoclonal antibodies against class 1 protein have high in vitro bactericidal activity and show high protective capacity in an animal model, whereas those against class 2 or 3 protein are much less effective (18, 19) . With an experimental OMC vaccine, the bactericidal activity of human volunteers was found to be correlated with a high response to class 1 protein (26, 27) . In the present study, a set of isogenic strains differing only in class 1 and class 3 proteins has allowed an unambiguous analysis of the contribution of each of these proteins in the induction of bactericidal antibodies with OMCs. Our results clearly demonstrate the dominant role of the subtype-specific sequences of class 1 protein.
This study further demonstrates that a major problem associated with OMP-based meningococcal vaccines, i.e., their limited range of protection, can be tackled by inserting multiple class 1 genes into a single strain. We are currently extending this approach to a third gene. In addition to class 3 protein, which induces hardly any bactericidal antibodies, removal of class 4 protein is also desirable since it might induce blocking antibodies (7) . Strains containing different combinations of three class 1 subtypes can then easily be constructed through repeated transformation. By mixing OMCs from two such strains, a multivalent vaccine potentially protecting against a number of the most prevalent subtypes can be obtained.
